title: Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.
authors.forename: C
authors.initials: C
authors.lastname: Zinkernagel
authors.forename: B
authors.initials: B
authors.lastname: Ledergerber
authors.forename: M
authors.initials: M
authors.lastname: Battegay
authors.forename: R W
authors.initials: RW
authors.lastname: Cone
authors.forename: P
authors.initials: P
authors.lastname: Vernazza
authors.forename: B
authors.initials: B
authors.lastname: Hirschel
authors.forename: M
authors.initials: M
authors.lastname: Opravil
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D018434:Sickness Impact Profile; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019438:Ritonavir